Physician profile
Khalid Akbar
NPI 1396749370
$3,270.80
in general payments reported to CMS, 2019-2025
18 companies · $585 in 2025
The $585 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $674 · 2020: $312 · 2021: $181 · 2022: $351 · 2023: $383 · 2024: $785 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,752.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $628.81 | 2019-2025 | |
| Glaxosmithkline, LLC. | $503.65 | 2019-2025 | Bexsero |
| Supernus Pharmaceuticals, INC. | $393.62 | 2021-2025 | Qelbree, Qelbree |
| Merck Sharp & Dohme LLC | $364.35 | 2019-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Sanofi Pasteur INC. | $314.72 | 2020-2025 | |
| Ironshore Pharmaceuticals INC. | $242.24 | 2019-2020 | |
| Corium, LLC | $206.18 | 2021-2025 | Azstarys |
| Cranial Technologies, INC | $150.95 | 2019-2025 | Doc Band |
| Neos Therapeutics, LP | $92.00 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $78.54 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $67.71 | 2025 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $56.43 | 2025 | |
| Sobi, INC | $41.26 | 2019 | |
| Novartis Pharmaceuticals Corporation | $32.60 | 2019 | |
| Tris Pharma INC | $31.45 | 2020-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $29.27 | 2022-2023 | Immunocap |
| Biomarin Pharmaceutical INC. | $21.10 | 2024 | Voxzogo 1.2mg |
| Ultragenyx Pharmaceutical INC. | $15.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalid Akbar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.